These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 38778725)

  • 1. Research advancements and perspectives of inflammatory bowel disease: A comprehensive review.
    Bai J; Wang Y; Li F; Wu Y; Chen J; Li M; Wang X; Lv B
    Sci Prog; 2024; 107(2):368504241253709. PubMed ID: 38778725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment Effects of Natural Products on Inflammatory Bowel Disease In Vivo and Their Mechanisms: Based on Animal Experiments.
    Zhou Y; Wang D; Yan W
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiome characterization and re-design by biologic agents for inflammatory bowel disease insights.
    Chen W; Chen H; Fu S; Lin X; Zheng Z; Zhang J
    Bioprocess Biosyst Eng; 2021 May; 44(5):929-939. PubMed ID: 32458051
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Musumeci L; Maugeri A; Cirmi S; Lombardo GE; Russo C; Gangemi S; Calapai G; Navarra M
    Nat Prod Res; 2020 Jan; 34(1):122-136. PubMed ID: 30990326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory bowel disease: exploring gut pathophysiology for novel therapeutic targets.
    Yadav V; Varum F; Bravo R; Furrer E; Bojic D; Basit AW
    Transl Res; 2016 Oct; 176():38-68. PubMed ID: 27220087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic Understanding of Herbal Therapy in Inflammatory Bowel Disease.
    Zhao L; Zhang S; He P
    Curr Pharm Des; 2017; 23(34):5173-5179. PubMed ID: 29032748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota and metabolites as predictors of biologics response in inflammatory bowel disease: A comprehensive systematic review.
    Wang C; Gu Y; Chu Q; Wang X; Ding Y; Qin X; Liu T; Wang S; Liu X; Wang B; Cao H
    Microbiol Res; 2024 May; 282():127660. PubMed ID: 38442454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
    Magro F; Portela F
    BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current Perspectives.
    Yang C; Merlin D
    Int J Nanomedicine; 2019; 14():8875-8889. PubMed ID: 32009785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which long noncoding RNAs and circular RNAs contribute to inflammatory bowel disease?
    Lin L; Zhou G; Chen P; Wang Y; Han J; Chen M; He Y; Zhang S
    Cell Death Dis; 2020 Jun; 11(6):456. PubMed ID: 32541691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of long non-coding RNA in inflammatory bowel disease.
    Hu Y; Lu Y; Fang Y; Zhang Q; Zheng Z; Zheng X; Ye X; Chen Y; Ding J; Yang J
    Front Immunol; 2024; 15():1406538. PubMed ID: 38895124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of Saccharomyces boulardii as a treatment option in IBD.
    Sivananthan K; Petersen AM
    Immunopharmacol Immunotoxicol; 2018 Dec; 40(6):465-475. PubMed ID: 29771163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of proton pump inhibitors on inflammatory bowel disease: An updated review.
    Liang Y; Meng Z; Ding XL; Jiang M
    World J Gastroenterol; 2024 Jun; 30(21):2751-2762. PubMed ID: 38899331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of nano formulation of natural products for the treatment of inflammatory bowel disease: drug delivery and pharmacological targets.
    Taghipour YD; Bahramsoltani R; Marques AM; Naseri R; Rahimi R; Haratipour P; Iranpanah A; Panah AI; Farzaei MH; Abdollahi M
    Daru; 2018 Dec; 26(2):229-239. PubMed ID: 30382546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paediatric Inflammatory Bowel Disease and its Relationship with the Microbiome.
    Fitzgerald RS; Sanderson IR; Claesson MJ
    Microb Ecol; 2021 Nov; 82(4):833-844. PubMed ID: 33666710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential of Plant-sourced Phenols for Inflammatory Bowel Disease.
    Xiao HT; Wen B; Shen XC; Bian ZX
    Curr Med Chem; 2018; 25(38):5191-5217. PubMed ID: 28990509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural Products: Experimental Efficient Agents for Inflammatory Bowel Disease Therapy.
    Cao F; Liu J; Sha BX; Pan HF
    Curr Pharm Des; 2019; 25(46):4893-4913. PubMed ID: 31840596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coumarin Derivatives in Inflammatory Bowel Disease.
    Di Stasi LC
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33467396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of small-molecule candidates against inflammatory bowel disease.
    Bai R; Jie X; Yao C; Xie Y
    Eur J Med Chem; 2020 Jan; 185():111805. PubMed ID: 31703817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.